Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003400832 | SCV004137402 | benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | AHNAK2: BS1, BS2 |
Ambry Genetics | RCV004364523 | SCV004877158 | uncertain significance | not specified | 2023-02-09 | criteria provided, single submitter | clinical testing | The c.3428C>G (p.A1143G) alteration is located in exon 7 (coding exon 7) of the AHNAK2 gene. This alteration results from a C to G substitution at nucleotide position 3428, causing the alanine (A) at amino acid position 1143 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV003400832 | SCV005296773 | benign | not provided | criteria provided, single submitter | not provided |